BZW2

eIF5-mimic protein 1 · Q9Y6E2 · BZW2 on Sugi Atlas →

0 patent compounds predicted against BZW2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to BZW2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL PHASE1/PHASE2RECRUITING
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
Study of the Beach Regimen on Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) PHASE2ACTIVE_NOT_RECRUITING
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. PHASE1/PHASE2RECRUITING
Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma PHASE2WITHDRAWN
Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors PHASE1ACTIVE_NOT_RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
First in Human Dose Escalation Study of Vactosertib (TEW-7197) in Subjects With Advanced Stage Solid Tumors PHASE1COMPLETED
A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors PHASE1COMPLETED
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING
Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors nanACTIVE_NOT_RECRUITING
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
Quantification of GADD34 Expression in RA nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED
Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors nanNOT_YET_RECRUITING
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
The Correlation Between Anemia of Chronic Diseases, Hepcidin and Vitamin D in IBD Patients nanUNKNOWN
Timisnar - Biomarkers Substudy (Timisnar-mirna) nanUNKNOWN
Generating Intervals of Reference FFor Early Life Brain Biomarkers. nanRECRUITING
The Molecular Pathogenesis Study of Cataract nanUNKNOWN
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA nanRECRUITING
Target of Suv420h1/2 in Hepatocytes nanRECRUITING
Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRI nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a BZW2 binder may also engage these)

ProteinNameSimilarity
Q2L4X1 1.000 Q2L4X1 →
Q4R6R4 1.000 Q4R6R4 →
Q91VK1 1.000 Q91VK1 →
Q9WTT7 1.000 Q9WTT7 →
Q5ZL42 1.000 Q5ZL42 →
Q1LUC1 0.997 Q1LUC1 →
Q5ZLT7 0.996 Q5ZLT7 →
Q6PD83 0.994 Q6PD83 →
Q9CQC6 0.992 Q9CQC6 →
Q6P7P5 0.991 Q6P7P5 →
BZW1 eIF5-mimic protein 2 0.991 landscape →
Q8AVM7 0.988 Q8AVM7 →
Q5R7L4 0.988 Q5R7L4 →
Q6P2Z0 0.988 Q6P2Z0 →
Q5ZJZ6 0.982 Q5ZJZ6 →
Q56A27 0.981 Q56A27 →
Q6GQ80 0.979 Q6GQ80 →
Q5ZMW3 0.979 Q5ZMW3 →
C0H906 0.978 C0H906 →
O35841 0.978 O35841 →
Q6GQD0 0.978 Q6GQD0 →
Q6DIE2 0.977 Q6DIE2 →
Q5R644 0.977 Q5R644 →
NCBP1 Nuclear cap-binding protein subunit 1 0.977 landscape →
A2AT37 0.977 A2AT37 →
Q3UYV9 0.976 Q3UYV9 →
Q9HAU5 0.976 Q9HAU5 →
Q7TPD0 0.975 Q7TPD0 →
B1MTK1 0.975 B1MTK1 →
Q5RE70 0.974 Q5RE70 →